SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001634432-19-000010
Filing Date
2019-08-13
Accepted
2019-08-13 08:48:30
Documents
3
Period of Report
2019-08-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbbp-20190813x8k.htm 8-K 49631
2 EX-99.1 sbbp-20190813ex991429ac1.htm EX-99.1 17652
3 GRAPHIC sbbp20190813ex991429ac1001.jpg GRAPHIC 3422
  Complete submission text file 0001634432-19-000010.txt   73462
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 191018334
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1